비호르몬 피임 시장 : 시장 규모, 점유율, 성장 분석 - 방법별, 성별, 입수 가능성별, 연령층별, 유통 채널별, 최종 사용자별, 지역별 업계 예측(2026-2033년)

Global Non-Hormonal Contraception Market size was valued at USD 32.66 Billion in 2024 and is poised to grow from USD 34.79 Billion in 2025 to USD 57.57 Billion by 2033, growing at a CAGR of 6.5% during the forecast period (2026-2033).

The global market for non-hormonal contraception encompasses various methods that effectively prevent fertilization or implantation without relying on hormones. Key categories include barrier methods, such as male and female condoms, diaphragms, and cervical caps, which create a physical barrier between sperm and egg and are known for their wide availability and minimal side effects. Additionally, fertility awareness-based methods utilize menstrual cycle tracking to identify fertile windows, requiring precise monitoring for effectiveness. Intrauterine devices (IUDs), specifically non-hormonal types like copper IUDs, offer a long-lasting solution by preventing fertilization and requiring less daily management. Although highly effective, such methods face challenges like the need for consistent use and potential discomfort during insertion, highlighting the importance of user education and healthcare guidance in maximizing their effectiveness.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Non-Hormonal Contraception market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Non-Hormonal Contraception Market Segments Analysis

Global Non-Hormonal Contraception Market is segmented by Method, Gender, Accessibility, Age Group, Distribution Channel, End User and region. Based on Method, the market is segmented into Barrier Method, Spermicidal, Sterilization and Other Methods. Based on Gender, the market is segmented into Male and Female. Based on Accessibility, the market is segmented into Over-the-Counter (OTC) and Prescription-Based. Based on Age Group, the market is segmented into 13-19 Years, 20-29 Years, 30-39 Years and 40+ Years. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, Online Platforms, Government & NGO Distribution Channels and Others. Based on End User, the market is segmented into Hospital, Clinics, Ambulatory Surgical Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Non-Hormonal Contraception Market

A significant factor driving the global non-hormonal contraception market is the rising awareness surrounding contraceptive options. As more individuals prioritize family planning and search for safe and effective methods, there is a notable shift towards non-hormonal alternatives. Access to educational resources and counseling services has played a vital role in enhancing consumer knowledge about various contraceptive methods, leading to an increased preference for non-hormonal solutions. This demand has prompted manufacturers to focus on developing innovative non-hormonal contraceptive products that cater to the diverse needs of consumers, who increasingly seek options that align with their health preferences and lifestyle choices.

Restraints in the Global Non-Hormonal Contraception Market

The global non-hormonal contraception market encounters significant challenges, particularly in developing regions where access and awareness are considerably limited. Inadequate infrastructure and resources restrict the availability of non-hormonal contraceptive options, creating barriers to effective contraception. Furthermore, cultural and religious beliefs in various communities contribute to the reluctance surrounding contraceptive use, further complicating market expansion. These factors not only lead to increased instances of unintended pregnancies but also elevate the rates of sexually transmitted infections, which ultimately stymie the growth prospects for the non-hormonal contraception market. Addressing these obstacles is essential for fostering a more robust and accessible market.

Market Trends of the Global Non-Hormonal Contraception Market

The global non-hormonal contraception market is witnessing a notable trend towards the rising demand for natural and organic contraceptive solutions. As consumers become increasingly educated about the potential adverse effects of hormonal contraceptives, they are actively seeking alternatives that are devoid of synthetic hormones and chemicals. This shift is fostering the popularity of non-hormonal options, including traditional condoms and various natural family planning methods, which are viewed as safer and more environmentally friendly. Furthermore, the growing emphasis on sustainability and eco-consciousness continues to propel this trend, as consumers prioritize products that align with their health and environmental values.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impact Factor
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index
• Clinical Trial Analysis
• Patent Analysis
• Case Study Analysis
• PESTEL Analysis
• Regulatory Analysis
• Pipeline Analysis
• Technology Analysis
• Fertility Awareness Method Users

Global Non-Hormonal Contraception Market Size by Method (Value/Volume) (2019-2032)

• Market Overview
• Barrier Method
  • Condoms
  • Male
  • Female
  • Diaphragms
  • Cervical Caps
  • Non-Hormonal IUDs
  • Contraceptive Sponges
  • Other Devices
• Spermicidal
• Sterilization
  • Male Sterilization (Vasectomy)
  • No-scalpel Vasectomy
  • Conventional Vasectomy
  • Minimally Invasive Vasectomy
  • Female Sterilization (Tubal Ligation)
  • Laparoscopic Tubal Ligation
  • Hysteroscopic Tubal Ligation
  • Mini-Laparotomy
  • Other Tubal Procedures
• Other Methods

Global Non-Hormonal Contraception Market Size by Gender (2019-2032)

• Market Overview
• Male
• Female

Global Non-Hormonal Contraception Market Size by Accessibility (2019-2032)

• Market Overview
• Over-the-Counter (OTC)
• Prescription-Based

Global Non-Hormonal Contraception Market Size by Age Group (2019-2032)

• Market Overview
• 13-19 Years
• 20-29 Years
• 30-39 Years
• 40+ Years

Global Non-Hormonal Contraception Market Size by Distribution Channel (2019-2032)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Online Platforms
• Government & NGO Distribution Channels
• Others

Global Non-Hormonal Contraception Market Size by End-User (2019-2032)

• Market Overview
• Hospital
• Clinics
• Ambulatory Surgical Centers
• Others

Global Non-Hormonal Contraception Market Size (2019-2032)

• North America (By Method, By Gender, By Accessibility, By Age Group, By Distribution Channel, & By End-User)
  • US
  • Canada
• Europe (By Method, By Gender, By Accessibility, By Age Group, By Distribution Channel, & By End-User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (By Method, By Gender, By Accessibility, By Age Group, By Distribution Channel, & By End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (By Method, By Gender, By Accessibility, By Age Group, By Distribution Channel, & By End-User)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Method, By Gender, By Accessibility, By Age Group, By Distribution Channel, & By End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Dashboard

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025

Key Company Profiles

• Evofem Biosciences
  • Company Overview
  • Product Portfolio Overview
  • Financial Overview
  • Key Developments
• The following companies are listed for indicative purposes only. Similar information will be provided for each, with detailed financial data available exclusively for publicly listed companies.
• Dare Bioscience
• CooperSurgical (Cooper Co.)
• Reckitt Benckiser
• Trojan
• Mayer Laboratories Inc.
• LifeStyles Healthcare
• Kessel Medintim GmbH
• Contraline, Inc.
• YourChoice Therapeutics
• Contrel Europe
• NEXT Life Sciences
• Femasys Inc.
• Apothecus Pharmaceutical
• Sebela Pharmaceuticals (Sebela Women's Health)
• FemCap Inc.
• Mona Lisa N.V.
• Okamoto Industries, Inc.
• Fuji Latex Co., Ltd.
• Veru Inc.

Conclusion & Analyst Recommendations